These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9578732)

  • 1. [Comparative study of the ploidy and cell proliferation of malignant epithelial neoplasms of various origin (flow cytometric assay)].
    Bychkova NV; Meshkova IE; Pozharisskiĭ KM
    Vopr Onkol; 1998; 44(1):54-9. PubMed ID: 9578732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
    Masood S; Bui MM; Lu L
    Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aneuploidy and proliferative activity in breast cancer (flow-cytometric investigation)].
    Bychkova NV; Pozharisskiĭ KM
    Vopr Onkol; 1997; 43(2):171-5. PubMed ID: 9214117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA aneuploidy by flow cytometry is an independent prognostic factor in squamous cell carcinoma of the oral cavity.
    Hemmer J; Nagel E; Kraft K
    Anticancer Res; 1999; 19(2B):1419-22. PubMed ID: 10365116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral squamous cell carcinoma. Cytometric parameters of prognostic interest.
    Saiz-Bustillo R; Corchero-Martín G; García-Montesinos-Perea B; Gonzalez-Terán T; Sánchez-Santolino S
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):462-7. PubMed ID: 16264382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological indicators of aggressiveness in T1 ductal invasive breast cancer.
    Bucci B; Carico E; Rinaldi A; Froio F; Puce YM; D'Agnano I; Vecchione A; Brunetti E
    Anticancer Res; 2001; 21(4B):2949-55. PubMed ID: 11712792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA ploidy, proliferative capacity and intratumoral heterogeneity in primary and recurrent head and neck squamous cell carcinomas (HNSCC)--potential implications for clinical management and treatment decisions.
    Hass HG; Schmidt A; Nehls O; Kaiser S
    Oral Oncol; 2008 Jan; 44(1):78-85. PubMed ID: 17350326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Flow-cytometric study of aneuploidy and proliferative activity of endometrial cancer cells as indicators of tumor aggressiveness].
    Bychkova NV; Meshkova IE; Pozharisskiĭ KM
    Vopr Onkol; 1996; 42(2):57-62. PubMed ID: 8815635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a flow cytometric method to determine DNA ploidy of oesophageal cancer cells obtained by forceps biopsy samples during oesophago-gastro-duodenoscopy.
    Rickes S; Hauptmann S; Flath B; Abbenseth R; Zwiebel FM; Possinger K
    Onkologie; 2003 Feb; 26(1):32-7. PubMed ID: 12624515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell proliferation in ovarian carcinoma: superior accuracy of S-phase fraction (SPF) by DNA labeling index versus flow cytometric SPF, lack of independent prognostic power for SPF and DNA ploidy, and limited effect of SPF on tumor growth rate.
    Meyer JS; Gersell DJ; Yim S
    Gynecol Oncol; 2001 Jun; 81(3):466-76. PubMed ID: 11371140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-based analysis of DNA ploidy and cell proliferation within fine-needle samplings of breast tumors: a new approach using automated image cytometry.
    Truong K; Vielh P; Malfoy B; Klijanienko J; Dutrillaux B; Bourgeois CA
    Cancer; 1998 Oct; 84(5):309-16. PubMed ID: 9801206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of DNA ploidy status in patients with rectal cancer.
    Berczi C; Bocsi J; Bartha I; Math J; Balazs G
    Anticancer Res; 2002; 22(6B):3737-41. PubMed ID: 12552986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma: dNA aneuploidy identifies high-risk cases among the so-called 'low-risk' patients with well and moderately differentiated tumors.
    Susini T; Amunni G; Molino C; Carriero C; Rapi S; Branconi F; Marchionni M; Taddei G; Scarselli G
    Cancer; 2007 Mar; 109(5):882-90. PubMed ID: 17262824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of GKLF messenger RNA and protein expression during progression of breast cancer.
    Foster KW; Frost AR; McKie-Bell P; Lin CY; Engler JA; Grizzle WE; Ruppert JM
    Cancer Res; 2000 Nov; 60(22):6488-95. PubMed ID: 11103818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers.
    Martinez-Arribas F; Nuñez-Villar MJ; Lucas AR; Sanchez J; Tejerina A; Schneider J
    Breast Cancer Res Treat; 2005 Jul; 92(1):77-80. PubMed ID: 15980994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of primary solid malignant neoplasms in different age groups as seen in our practice.
    Ahmed Z; Azad NS; Rauf F; Yaqoob N; Husain A; Ahsan A; Ahmed R; Kayani N; Pervez S; Hassan SH
    J Ayub Med Coll Abbottabad; 2007; 19(3):56-63. PubMed ID: 18444593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The cytospectrophotometric study of the DNA content in benign and malignant processes in the breast].
    Borodaĭ NV
    Tsitol Genet; 1999; 33(3):27-33. PubMed ID: 10474860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.